½ÃÀ庸°í¼
»óÇ°ÄÚµå
1547470
¼¼°èÀÇ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)Global Women Health Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 882¾ï 8,000¸¸ ´Þ·¯¿¡¼ 2032³â ¾à 1,506¾ï 8,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2024-2032³â ¿¬Æò±Õ 6.12%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀӽŠ°ü·Ã ÇÕº´Áõ, °¨¿°, ÀڱðæºÎ¾Ï, ³¼Ò¾Ï, ÀÚ±ÃüºÎ¾Ï µîÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â Ä¡·áÁ¦, ¿ä¹ý, ¾àÇ°Àº ¿©¼º °Ç° Ä¡·áÁ¦·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÃÖ±Ù ¿©¼º ºÒÀÓÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ãâ»êÀÌ ´Ê¾îÁö´Â »ç¶÷µéÀ» À§ÇÑ ºÒÀÓ Ä¡·áÁ¦ ¼ºñ½º Á¦°øÀÌ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿©¼º ¼º±â´É Àå¾Ö Ä¡·áÁ¦¿¡ ´ëÇÑ ¹ÌÃæÁ· ¼ö¿ä°¡ ¿©¼º °Ç° Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
¿©¼º °Ç°°ú ±× Ä¡·áÁ¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. °¨¿°¼º Áúȯ, ¾Ï, ÀӽŰú °°Àº ¹®Á¦ Ä¡·áÁ¦¿Í °ü·ÃµÈ ÀǾàÇ°¿¡ ´ëÇÑ ¹ÌÃæÁ· ¼ö¿ä¸¦ ÃæÁ·½ÃÅ°±â À§ÇÑ ³ôÀº ÅõÀÚµµ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿øµ¿·Â Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¿©¼º °Ç° °ü·Ã ¸¸¼ºÁúȯ ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀÌ È®»êµÇ°í ÀÖ´Â °Íµµ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ÀÖ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿©¼º¿¡°Ô ´õ ³ªÀº °Ç°À» Á¦°øÇϱâ À§ÇÑ ¿¬±¸ °³¹ß À̴ϼÅƼºêÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ³ª»Û ¿µ¾ç ¼·Ãë¿Í »ýÈ°½À°ü º¯Èµµ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀå ¼ºÀå¿¡ È°·ÂÀ» ºÒ¾î³ÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Ä¡·áÁ¦¿¡ µû¸¥ ³ôÀº Ä¡·á ºñ¿ë°ú Ä¡·áÁ¦ÀÇ »ç¿ë¿¡ µû¸¥ ºÎÀÛ¿ëÀº ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÏ´Â ¿äÀÎÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
Á¶»ç º¸°í¼´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆľÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¿©¼º °Ç° Ä¡·áÁ¦ ¼¼°è ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©¼º °Ç° Ä¡·áÁ¦ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼³¸íÇÕ´Ï´Ù.
¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¹× ¼ºñ½ºÀÇ Å¸°ÙÃþÀ» ½Äº°ÇÏ°í ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿©¼º °Ç° Ä¡·áÁ¦ ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ÀúÈñ¿¡°Ô ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
The global demand for Women Health Therapeutics Market is presumed to reach the market size of nearly USD 150.68 Billion by 2032 from USD 88.28 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.
A treatment, therapy, or drug that is used for the diagnosis of issues like pregnancy-related complications, infection, cervical cancer, ovarian cancer, and uterine cancer, etc is known as women's health therapeutics. Nowadays, infertility cases in women are rising, so the focus on providing fertility services to those with delayed childbirth is increasing. And, the unmet needs of the treatment of female sexual dysfunction are leading to the demand for women's health therapeutics.
Rising awareness about women's health and its treatment is the key market driver for the growth of the women's health therapeutics market. High investments made to meet the unmet demands of drugs related to the treatment of issues like infections, cancer, pregnancy, etc is also one of the major driving force responsible for the market growth of women health therapeutics. The growing prevalence of prevention of chronic diseases related to women's health is also assumed to steer the market growth of women's health therapeutics. An increase in research and development initiatives for providing better health to women will further propel the market growth. Furthermore, bad nutritional intake and change in lifestyle are also expected to increase the demand for therapeutics and exhilarate the market growth of women's health therapeutics. However, the high treatment cost associated with the treatment and side effects associated with the usage of the therapeutics may restraint the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Women Health Therapeutics. The growth and trends of Women Health Therapeutics industry provide a holistic approach to this study.
This section of the Women Health Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Women Health Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Women Health Therapeutics market include Eli Lilly And Company, Novartis AG, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, GlaxoSmithKline Plc, Lupin Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.